OriV508 Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OriV508 Injection, covering 2025-09-09 to 2025-09-09. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies [EARLY_Phase 1]